JP2001518879A - 薬剤化合物の向上した浸透性のための溶媒システム - Google Patents

薬剤化合物の向上した浸透性のための溶媒システム

Info

Publication number
JP2001518879A
JP2001518879A JP54163598A JP54163598A JP2001518879A JP 2001518879 A JP2001518879 A JP 2001518879A JP 54163598 A JP54163598 A JP 54163598A JP 54163598 A JP54163598 A JP 54163598A JP 2001518879 A JP2001518879 A JP 2001518879A
Authority
JP
Japan
Prior art keywords
drug
pharmaceutical composition
composition according
topical pharmaceutical
active drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP54163598A
Other languages
English (en)
Japanese (ja)
Inventor
ラオ,チャクラダーラ
リウ,ジュー−チェン
ワン,ジョナス,シー,ティー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Publication of JP2001518879A publication Critical patent/JP2001518879A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP54163598A 1997-03-31 1998-03-03 薬剤化合物の向上した浸透性のための溶媒システム Pending JP2001518879A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82909197A 1997-03-31 1997-03-31
US08/829,091 1997-03-31
PCT/US1998/004033 WO1998043673A1 (en) 1997-03-31 1998-03-03 Solvent system for enhanced penetration of pharmaceutical compounds

Publications (1)

Publication Number Publication Date
JP2001518879A true JP2001518879A (ja) 2001-10-16

Family

ID=25253504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54163598A Pending JP2001518879A (ja) 1997-03-31 1998-03-03 薬剤化合物の向上した浸透性のための溶媒システム

Country Status (14)

Country Link
EP (1) EP0971746A1 (es)
JP (1) JP2001518879A (es)
KR (1) KR19980081207A (es)
CN (1) CN1252003A (es)
AR (1) AR012217A1 (es)
AU (1) AU6677698A (es)
BR (1) BR9811458A (es)
CA (1) CA2285368A1 (es)
CO (1) CO5050328A1 (es)
HU (1) HUP0001739A3 (es)
IL (1) IL132096A0 (es)
PL (1) PL335934A1 (es)
WO (1) WO1998043673A1 (es)
ZA (1) ZA982662B (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10287588A (ja) * 1997-04-10 1998-10-27 Roche Consumer Health Worldwide Ltd 医薬製剤
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
JP2005036000A (ja) * 2003-07-03 2005-02-10 Taisho Pharmaceut Co Ltd 容器への吸着を防止した外用抗真菌組成物
US8492421B2 (en) 2007-08-27 2013-07-23 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000072818A1 (en) * 1999-05-27 2000-12-07 The Procter & Gamble Company Topical compositions providing improved treatment of skin or scalp fungal infections
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
MY129350A (en) * 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
US20080032994A1 (en) 2006-08-03 2008-02-07 Marcel Borgers Modified azole compounds as antifungal and antibacterial agents
WO2009013331A1 (en) * 2007-07-25 2009-01-29 Ixodes Gmbh Topical antibiotic composition for the prevention of lyme disease
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US9839611B2 (en) * 2013-09-10 2017-12-12 Insys Development Company, Inc. Sublingual buprenorphine spray
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
CN105848719A (zh) 2013-11-22 2016-08-10 道尔医药科学公司 抗感染的方法、组合物和装置
CN115745757B (zh) * 2022-11-07 2024-04-26 中国人民解放军军事科学院军事医学研究院 一种液态多甘醇柱芳烃衍生物的合成及对经皮药效分子缓释的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051998T3 (es) * 1988-02-29 1994-07-01 Pfizer Composiciones aumentadoras del flujo transdermal.
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10287588A (ja) * 1997-04-10 1998-10-27 Roche Consumer Health Worldwide Ltd 医薬製剤
JP4580476B2 (ja) * 1997-04-10 2010-11-10 ロシュ コンシューマー ヘルス (ワールドワイド) エスエー 医薬製剤
WO2005002561A1 (ja) * 2003-07-03 2005-01-13 Taisho Pharmaceutical Co.,Ltd. 外用抗真菌剤組成物
JP2005036000A (ja) * 2003-07-03 2005-02-10 Taisho Pharmaceut Co Ltd 容器への吸着を防止した外用抗真菌組成物
JPWO2005002561A1 (ja) * 2003-07-03 2006-10-19 大正製薬株式会社 外用抗真菌剤組成物
JP5435836B2 (ja) * 2003-07-03 2014-03-05 大正製薬株式会社 外用抗真菌剤組成物
US8492421B2 (en) 2007-08-27 2013-07-23 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis
JP5313905B2 (ja) * 2007-08-27 2013-10-09 日本農薬株式会社 真菌性皮膚炎用剤
US8835479B2 (en) 2007-08-27 2014-09-16 Nihon Nohyaku Co., Ltd. Agent for fungal dermatitis

Also Published As

Publication number Publication date
AR012217A1 (es) 2000-09-27
CO5050328A1 (es) 2001-06-27
EP0971746A1 (en) 2000-01-19
BR9811458A (pt) 2000-09-19
HUP0001739A3 (en) 2001-04-28
PL335934A1 (en) 2000-05-22
IL132096A0 (en) 2001-03-19
KR19980081207A (ko) 1998-11-25
AU6677698A (en) 1998-10-22
ZA982662B (en) 1999-09-30
HUP0001739A2 (hu) 2000-12-28
CN1252003A (zh) 2000-05-03
WO1998043673A1 (en) 1998-10-08
CA2285368A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
JP2001518879A (ja) 薬剤化合物の向上した浸透性のための溶媒システム
JP2779303B2 (ja) 水系ゲルのレチノイド服用形態
JP2002509867A (ja) 爪と皮膚の局所治療用酸性化組成物
RU2699651C1 (ru) Распыляемые носитель и композиция для местного применения, содержащие фосфатидилхолин
US20220273627A1 (en) Topical composition comprising tacrolimus
EP1138314A2 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
EP1874320A1 (en) Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
JP2646025B2 (ja) コルチコステロイド含有ローション剤
US20130115181A1 (en) Aqueous pharmaceutical system for the administration of drugs to the nails
SE1300709A1 (sv) Komposition och metod för topikal behandling
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
AU2953992A (en) Skin care composition
AU661283B2 (en) Topical composition
JPH0371409B2 (es)
WO2014017411A1 (ja) 爪白癬治療用外用剤
US20110300086A1 (en) Film-Forming Solutions Comprising Vitamin D or Derivative Thereof and a Corticosteroid and Dermatological Applications Thereof
US5807569A (en) Topical composition
RU2730010C2 (ru) Водно-спиртовая система для лечения ногтей
US8257688B2 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
CZ345699A3 (cs) Rozpouštědlový systém pro zvýšenou penetraci farmaceutických sloučenin
CN118317767A (zh) 包含噻托溴铵的水包油乳液凝胶
JPH0611716B2 (ja) 経皮吸収促進剤